Table A4.
Decreases in LVEF by Change of Markers From Baseline Levels
Baseline Marker Change | No. of Patients/Total No. of Patients (%) With Decrease in LVEF* |
P | |
---|---|---|---|
Yes | No | ||
BNP normal at baseline to double postbaseline and > 40 ng/mL | 3/11 (27) | 3/44 (7) | .09 |
TnT normal at baseline to abnormal postbaseline | 2/14 (14) | 6/51 (12) | 1.00 |
TnI normal at baseline to abnormal postbaseline | 3/11 (27) | 14/49 (29) | 1.00 |
TnT and TnI both normal at baseline to both abnormal postbaseline | 1/11 (9) | 5/48 (10) | 1.00 |
CRP normal at baseline to abnormal postbaseline | 5/8 (63) | 13/32 (41) | .43 |
TNF-α normal at baseline to abnormal postbaseline | 2/14 (14) | 6/51 (12) | 1.00 |
IL-6 normal at baseline to abnormal postbaseline | 0/13 | 3/48 (6) | 1.00 |
IL-1β normal at baseline to abnormal postbaseline | 0/13 | 2/46 (4) | 1.00 |
Abbreviations: BNP, brain natriuretic peptide; CRP, C-reactive protein; IL, interleukin; LVEF, left ventricular ejection fraction; Tn, troponin; TNF, tumor necrosis factor.
Decrease in LVEF measure was defined as a decrease of 10% to 15% from baseline to below the lower limit of normal or a decrease in LVEF > 15%.